Search results
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
CNBC· 1 day agoModerna has more to offer beyond its Covid vaccine. The biotech company Wednesday announced positive...
Moderna shares continue to fall even as its 3 vaccines enter final stage trials | Invezz
Invezz· 24 hours agoModerna Inc. saw its stock continue its downward trajectory on Wednesday, slipping by 1.2% to...
Moderna unveils robust next-gen COVID-19 vaccine pipeline progress By Investing.com
Investing.com· 1 day agoThe company expects regulatory approval and U.S. launch for its RSV vaccine in 2024, following...
Blackstone funds Moderna's flu vaccine program with $750 million By Investing.com
Investing.com· 1 day agoIn a significant move within the pharmaceutical industry, Blackstone (NYSE:BX) Life Sciences, part...
Moderna Gets $750 Million for Flu Program to Help Move Beyond Covid Vaccines
Barrons.com· 1 day ago“Achieving this ambition requires substantial investment in late-stage studies and we...
Moderna Says 'Next-Generation' COVID-19 Shot Had Positive Phase 3 Test Results
Investopedia· 2 days agoChief Executive Officer (CEO) Stephane Bancel explained that mRNA-1283 is a “critical component” of...
Moderna gets Blackstone backing for flu vaccine R&D
BioPharma Dive via Yahoo Finance· 1 day agoAn arm of the private equity firm pledged up to $750 million in funding for Moderna’s flu shot development, in exchange for milestones and royalties.
Moderna secures $750 million from Blackstone Life Sciences to develop flu shots
KFGO· 1 day ago(Reuters) -Moderna said on Wednesday it has entered into an agreement with private equity firm...
Moderna's next-gen COVID-19 vaccine shows higher immune response By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) reported on Monday that its next-generation COVID-19 vaccine,...
Blackstone bets $750M on Moderna's flu program as approval comes into view
FierceBiotech· 1 day agoBlackstone Life Sciences is making a $750 million bet on Moderna’s influenza vaccine program as part...